MPTP induces intranuclear rodlet formation in midbrain dopaminergic neurons

Brain Research

Volumn 1066, Issue 1-2, 2005, Pages 86-91

  Lamba, Wiplove ^a   Prichett, Wendy ^b   Munoz, David ^c   Park, David S ^a,b   Woulfe, John M ^a,b,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Class III beta tubulin; Intranuclear inclusion; Intranuclear rodlet; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BETA TUBULIN; GLUCOCORTICOID RECEPTOR; NEUROTOXIN; SODIUM CHLORIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DOPAMINERGIC NERVE CELL; IMMUNOREACTIVITY; LEWY BODY; MESENCEPHALON; MICROTUBULE; MOTOR DYSFUNCTION; MOUSE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PILOT STUDY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SUBSTANTIA NIGRA; TEMPORAL CORTEX; VENTRAL TEGMENTUM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CELL NUCLEUS; DOPAMINE; DOPAMINE AGENTS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; NEURONS; RECEPTORS, GLUCOCORTICOID; TUBULIN; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 29044432628     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.10.058     Document Type: Article

References (35)

1. M.A. Alim, M.S. Hossain, K. Arima, K. Takeda, Y. Izumiyama, M. Nakamura, H. Kaji, T. Shinoda, S. Hisanaga, and K. Ueda Tubulin seeds α-synuclein fibril formation J. Biol. Chem. 277 2002 2112 2117
2. M. Arrasate, S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810
3. M. Berciano, N.T. Villagra, J.L. Ojeda, J. Navascues, A. Gomes, M. Lafarga, and M. Carmo-Fonseca Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus Hum. Mol. Genet. 13 2004 829 838
4. D. Burke, P. Gasdaska, and L. Hartwell Dominant effects of tubulin overexpression in Saccharomyces cerevisiae Mol. Cell. Biol. 9 1989 1049 1059
5. R.Y.S. Cajal Histologie du systeme nerveux de l'homme et des vertebres II Trans L. Azouly 1911 Maloine Paris
6. G. Cappelletti, C. Incani, and R. Maci Involvement of tubulin in MPP+ neurotoxicity on NGF-differentiated PC12 cells Cell Biol. Int. 19 1995 687 693
7. G. Cappelletti, M.G. Maggioni, and R. Maci Influence of MPP+ on the state of tubulin polymerization in NGF-differentiated PC12 cells J. Neurosci. Res. 56 1999 28 35
8. G. Cappelletti, B. Pedrotti, M.G. Maggioni, and R. Maci Microtubule assembly is directly affected by MPP(+) in vitro Cell Biol. Int. 25 2001 981 984
9. A.D. Cash, G. Aliev, S.L. Siedlak, A. Nunomura, H. Fujioka, X. Zhu, A.K. Raina, H.V. Vinters, M. Tabaton, A.B. Johnson, M. Paula-Barbosa, J. Avila, P.K. Jones, R.J. Castellani, M.A. Smith, and G. Perry Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation Am. J. Pathol. 162 2003 1623 1627
10. P.G. Galloway, P. Mulvihill, and G. Perry Filaments of Lewy bodies contain insoluble cytoskeletal elements Am. J. Pathol. 140 1992 809 822
11. D.A. Gray Damage control-A possible non-proteolytic role for ubiquitin in limiting neurodegeneration Neuropathol. Appl. Neurobiol. 27 2001 89 94
12. H. Hallman, L. Olson, and G. Jonsson Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse Eur. J. Pharmacol. 97 1984 133 136
13. H. Hallman, J. Lange, L. Olson, I. Stromberg, and G. Jonsson Neurochemical and histochemical characterization of neurotoxic effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse J. Neurochem. 44 1985 117 127
14. R.E. Heikkila, B.A. Sieber, L. Manzino, and P.K. Sonsalla Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in the mouse Mol.Chem. Neuropathol. 10 1989 171 183
15. V. Jackson-Lewis, M. Jakowec, R.E. Burke, and S. Przedborski Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurodegeneration 4 1995 257 269
16. M. Lafarga, M.T. Berciano, and M.A. Andres Protein-synthesis inhibition induces perichromatin granule accumulation and intranuclear rodlet formation in osmotically stimulated supraoptic neurons Anat. Embryol. (Berl.) 187 1993 363 369
17. J.W. Langston, and I. Irwin MPTP: current concepts and controversies Clin. Neuropharmacol. 9 1986 485 507
18. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
19. G. Mann Histological changes induced in sympathetic, motor, and sensory nerve cells by functional activity Anat. Physiol. 29 1894 100 108
20. G. Marinesco Sur la presence des corpuscles acidophiles paranucleolaires dans les cellules du locus niger et du locus ceruleus C. R. Acad. Sci. 135 1902 1000 1002
21. R.M. Miller, L.M. Callahan, C. Casaceli, L. Chen, G. Kiser, B. Chui, T.M. Kaysser-Kranich, T.J. Sendera, C. Palaniappan, and H.J. Federoff Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra J. Neurosci. 24 2004 7445 7454
22. H.T. Orr Neuron protection agency Nature 431 2004 747 748
23. D. Pollack, N. Cairns, and G. Lubec Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer's disease and Pick's disease J. Neural Transm., Suppl. 67 2003 149 158
24. Y. Ren, J. Zhao, and J. Feng Parkin binds to α/β tubulin and increases their ubiquitination and degradation J. Neurosci. 23 2003 3316 3324
25. G.A. Ricaurte, I. Irwin, L.S. Forno, L.E. deLanney, E. Langston, and A.W. Langston Aging and 1-methyl-4-phenyl-1,2,3,6-terahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra Brain Res. 403 1987 43 51
26. C.A. Ross, and M.A. Poirier Protein aggregation and neurodegenerative disease Nat. Med. 10 2004 S10 S17 (Suppl.)
27. R. Seite, N. Mei, and J. Villet-Luciani Effect of electrical stimulation on nuclear microfilaments and microtubules of sympathetic neurons submitted to cycloheximide Brain Res. 50 1973 419 423
28. R. Seite, J. Leonetti, J. Luciani-Vuillet, and M. Vio Cyclic AMP and ultrastructural organization of the nerve cell nucleus: stimulation of nuclear microtubules and microfilaments assembly in sympathetic neurons Brain Res. 124 1977 41 51
29. K. Siegesmund, C. Dutta, and C. Fox The ultrastructure of the intranuclear rodlets in certain nerve cells J. Anat. 98 1964 93 97
30. F. Tronche, C. Kellendronk, O. Kretz, P. Gass, K. Anlag, P.C. Orban, R. Bock, R. Klein, and G. Schutz Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety Nat. Genet. 23 1999 99 103
31. S. Vijayan, E. El-Akkad, I. Grundke-Iqbal, and K. Iqbal A pool of beta-tubulin is hyperphosphorylated at serine residues in Alzheimer disease brain FEBS Lett. 509 2001 375 381
32. B. Weinstein, and F. Solomon Phenotypic consequences of tubulin overproduction in Saccharomyces cerevisiae: differences between α-tubulin and β-tubulin Mol. Cell. Biol. 10 1990 5295 5304
33. J. Woulfe, and D. Munoz Class III β-tubulin immunoreactive neuronal intranuclear inclusions in the human brain Neuropathol. Appl. Neurobiol. 26 2000 161 171
34. J.M. Woulfe, R. Hammond, B. Richardson, D. Sooriabalan, W. Parks, P. Rippstein, and D.G. Munoz Reduction of neuronal intranuclear rodlets immunoreactive for tubulin and glucocorticoid receptor in Alzheimer's disease Brain Pathol. 2002 300 307
35. J. Woulfe, D. Gray, W. Prichett, D. Munoz, and M. Chretien Intranuclear rodlets in the substantia nigra: interactions with Marinesco bodies, ubiquitin, and promyelocytic leukemia protein J. Neuropathol. Exp. Neurol. 63 2004 1200 1207